IMI2_TransBioLine

Translational Safety Biomarker Pipeline: Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

[IMI2_TransBioLine @IMITransBioLine]

As we are reaching the Project end, we would like to thank all Partners for their dedicated work over the last 6 years!
38 publications are just a small pict of the project impact on #biomarkers
👉 https://t.co/lDeamEy2jf
#IHICarryTheTorch #H2020 #EUHealthResearch @IHIEurope

[IMI2_TransBioLine @IMITransBioLine]

The entire TransBioLine team sends warm wishes for a wonderful year ahead!

@IHIEurope #IHICarrytheTorch #H2020 #EUHealthResearch

[IMI2_TransBioLine @IMITransBioLine]

During the latest @NottmBRC Conference, Jane Grove from @NottsLiverTeam presented results on the development of novel DILI safety #biomarkers

#IHICarryTheTorch #H2020 #EUHealthResearch @IHIEurope

[IMI2_TransBioLine @IMITransBioLine]

TransBioLine Project Coordinator Sophia Samodelov (@somucholives) participated in “Advancing Regulatory Science Research”, a recent event organised by @EMA_News

Full recording 👇
https://t.co/ZZLKu2Dm23

#biomarkers #IHICarryTheTorch #H2020 #EUHealthResearch @IHIEurope

[IMI2_TransBioLine @IMITransBioLine]

Technology for drug causality assessment in patients diagnosed with idiosyncratic DILI was presented during last @AASLDFoundation meeting

@IHIEurope #biomarkers #IHICarrytheTorch #H2020 #EUHealthResearch

[IMI2_TransBioLine @IMITransBioLine]

We're excited to announce that Sophia Samodelov, our Project Coordinator, will be a panelist at the upcoming “Advancing regulatory science research” event organised by @EMA on November 18!

Register by November 13
👉 https://t.co/sI5UuuL3oH

#biomarkers #H2020 @IHIEurope

[IMI2_TransBioLine @IMITransBioLine]

Thank you to all participants for your valuable contributions at the 9th TransBioLine Consortium Meeting! 👏

Find out more:
https://t.co/y2AiRpXizu

@IHIEurope #biomarkers #IHICarrytheTorch #H2020 #EUHealthResearch

[IMI2_TransBioLine @IMITransBioLine]

Prospective evaluation of DILI patients allowed the identification of a predictive histological parameter.

Results were presented during @my_ueg week by Julian Allgeier - @LMU_Uniklinikum

#biomarker #IngestTheBest #UEGWeek @IHIEurope #IHICarryTheTorch #H2020 #EUHealthResearch

[IMI2_TransBioLine @IMITransBioLine]

During the last @my_ueg week, the specific injury pattern for DILI due to metamizole was presented by Sabine Weber - @LMU_Uniklinikum

More information 👇
https://t.co/2LyUuHGIpO

@IHIEurope #biomarker #IngestTheBest #UEGWeek #IHICarryTheTorch #H2020 #EUHealthResearch

[EASLDHILIconsortium @easldhili]

🔛Final 9 TransBioLine F2F meeting in London. #H2020 #EUHealthResearch @IMITransBioLine
☑️Close to the project end, the focus is on the dissemination of results and sustainability.
☑️Promising results on DILI #biomarkers can be expected shortly. @StirnimannGuido

[IMI2_TransBioLine @IMITransBioLine]

Now that the 9th TransBioLine Consortium Meeting has ended, we would like to thank all participants for your valuable contributions!

#biomarkers @IHIEurope #IHICarrytheTorch #H2020 #EUHealthResearch

[IMI2_TransBioLine @IMITransBioLine]

Today’s main focus will be on the sustainability of the project outcomes. We will reflect together on defining the best way to secure the impact of our teamwork on safety #biomarkers

@IHIEurope #IHICarrytheTorch #H2020 #EUHealthResearch

[IMI2_TransBioLine @IMITransBioLine]

Day 1 focused on the latest advancements in safety #biomarker identification and qualification. Great progress has been disclosed! 👏

@IHIEurope #IHICarrytheTorch #H2020 #EUHealthResearch

[IMI2_TransBioLine @IMITransBioLine]

Shashi Ramaiah and Sophia Samodelov are welcoming all attendees and sharing the main objectives of this two-day meeting.

Excited to get started!

#biomarkers @IHIEurope #IHICarrytheTorch #H2020 #EUHealthResearch

[IMI2_TransBioLine @IMITransBioLine]

📆 23-24/09/2024
📍 London

The 9th Consortium Meeting is around the corner! We’re looking forward to this event to share the latest project achievements in safety #biomarkers qualification

@IHIEurope #IHICarrytheTorch #H2020 #EUHealthResearch

[IMI2_TransBioLine @IMITransBioLine]

Recent data on #miRNA for use as non-invasive #biomarkers of CNS-injury was presented during last @EUROTOX2024

#IHICarryTheTorch #H2020 #EUHealthResearch @IHIEurope #EUROTOX2024

[IMI2_TransBioLine @IMITransBioLine]

The results of the collaboration between our scientists leading to the identification of #miRNA to be used as #biomarkers for DIPI were presented at @EUROTOX2024

#IHICarryTheTorch #H2020 #EUHealthResearch @IHIEurope #EUROTOX2024

[IMI2_TransBioLine @IMITransBioLine]

The entire TransBioLine team is committed to improving patient safety by developing and qualifying safety #biomarkers for drug development

@IHIEurope @WHO #IHICarrytheTorch #H2020 #WPSD24 #WorldPatientSafetyDay

[IMI2_TransBioLine @IMITransBioLine]

During last Cutting Edge Pathology Congress, Warren Glaab presented the results of nonclinical studies to support identification and qualification of biomarkers for early DINI

#IHICarryTheTorch #H2020 #EUHealthResearch @IHIEurope

[IMI2_TransBioLine @IMITransBioLine]

TransBioLine experts in #biomarkers development and qualification are sharing their learning.

Check out this interview with Anthony Evans from @LivUniCBF

👉 https://t.co/4uHSfVf42F

#IHICarryTheTorch #H2020 #EUHealthResearch @IHIEurope